Effects of Liraglutide on GLP-1, GIP and glucagon concentrations in persons with type 2 diabetes with multiple daily insulin injections during a 24-week period

被引：0
|
作者：
Koci, M. [1 ]
Jansson, P. -A. [2 ]
Fatulla, P. [2 ]
Bergqvist, K. [3 ]
Ahmadi, S. Seyed [2 ]
Imberg, H. [2 ]
Hirsch, I. [4 ]
Mellander, O. [5 ]
Lind, M. [2 ]
机构：
[1] Sahlgrens Univ Hosp, Dept Endocrinol & Diabet, Gothenburg, Sweden
[2] Gothenburg Univ, Dept Mol & Clini cal Med, Gothenburg, Sweden
[3] Gothenburg Univ, Dept Infect Dis, Gothenburg, Sweden
[4] UW Med Diabet Inst, Div Metab Endocrinol & Nutr, Seattle, WA USA
[5] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
83
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [21] Effects of sitagliptin, acarbose and sulfonylureas on postprandial levels of GLP-1 and GIP in Japanese patients with type 2 diabetes
    Yabe, D.
    Watanabe, K.
    Sugawara, K.
    Kuwata, H.
    Kitamoto, Y.
    Sugizaki, K.
    Fujiwara, S.
    Hishizawa, M.
    Hyo, T.
    Kuwabara, K.
    Yokota, K.
    Iwasaki, M.
    Kitatani, N.
    Kurose, T.
    Seino, Y.
    DIABETOLOGIA, 2011, 54 : S342 - S342
  • [22] Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects With Type 2 Diabetes
    Pirro, Valentina
    Roth, Kenneth D.
    Lin, Yanzhu
    Willency, Jill A.
    Milligan, Paul L.
    Wilson, Jonathan M.
    Ruotolo, Giacomo
    Haupt, Axel
    Newgard, Christopher B.
    Duffin, Kevin L.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (02): : 363 - 378
  • [23] The role of GLP-1 mimetics and basal insulin analogues in type 2 diabetes mellitus: guidance from studies of liraglutide
    Barnett, A. H.
    DIABETES OBESITY & METABOLISM, 2012, 14 (04): : 304 - 314
  • [24] The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients
    Anne Flint
    Christoph Kapitza
    Charlotte Hindsberger
    Milan Zdravkovic
    Advances in Therapy, 2011, 28 : 213 - 226
  • [25] The Once-Daily Human Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Improves Postprandial Glucose Levels in Type 2 Diabetes Patients
    Flint, Anne
    Kapitza, Christoph
    Hindsberger, Charlotte
    Zdravkovic, Milan
    ADVANCES IN THERAPY, 2011, 28 (03) : 213 - 226
  • [26] Majority of persons with type 1 diabetes on multiple daily insulin injections benefit from continuous glucose monitoring
    Olafsdottir, A. F.
    Bolinder, J.
    Heise, T.
    Polonsky, W.
    Ekelund, M.
    Wijkman, M.
    Pivodic, A.
    Schwarcz, E.
    Nystrom, T.
    Hellman, J.
    Hirsch, I. B.
    Lind, M.
    DIABETOLOGIA, 2019, 62 : S22 - S22
  • [27] Differences in metabolic effects of twice daily versus multiple daily insulin injections in children with type 1 diabetes
    Abid, Noina
    Porter, Lesley
    Day, Emma
    Krone, Nils
    Hoegler, Wolfgang
    Kirk, Jeremy
    Shaw, Nick
    Barrett, Tim
    PRACTICAL DIABETES, 2011, 28 (09) : 384 - 387
  • [28] Liraglutide, a once-daily human GLP-1 analog, significantly improves β-cell function in subjects with type 2 diabetes
    Matthews, David
    Marre, Michel
    Le-Thl, T. U. Duyen
    Zdravkovic, Milan
    Simo, Rafael
    DIABETES, 2008, 57 : A150 - A151
  • [29] Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections
    Sofizadeh, Sheyda
    Imberg, Henrik
    Olafsdottir, Arndis F.
    Ekelund, Magnus
    Dahlqvist, Sofia
    Hirsch, Irl
    Filipsson, Karin
    Ahren, Bo
    Sjoberg, Stefan
    Tuomilehto, Jaako
    Lind, Marcus
    DIABETES THERAPY, 2019, 10 (06) : 2115 - 2130
  • [30] Effects of variations in duodenal glucose load on glycaemia, insulin and GLP-1 in type 2 diabetes
    Rayner, C. K.
    Ma, J.
    Pilichiewicz, A.
    Feinle-Bisset, C.
    Checklin, H. L.
    Wishart, J. M.
    Jones, K. L.
    Horowitz, M.
    DIABETOLOGIA, 2009, 52 : S105 - S106
12345